Global Sickle Cell Anemia Treatment Market Size, Status and Forecast 2019-2025

Published On: Jul 2019

Format: PDF

Publisher: QY Research

Pages: 98

Report ID: 19987

Sickle cell disease (SCD) is a chronic, inherited blood disorder that impacts hemoglobin, a protein found in red blood cells (RBCs) that carries oxygen throughout the body. The disease is caused by a genetic mutation in the beta-chain of hemoglobin, which results in the formation of abnormal hemoglobin known as sickle hemoglobin (HbS).
In the last several years, global market of Sickle Cell Anemia Therapeutics developed rapidly, with an average growth rate of 13.32% during 2013 to 2017. In 2017, global revenue of Sickle Cell Anemia Therapeutics is nearly 1900 M USD.
In 2018, the global Sickle Cell Anemia Treatment market size was 1900 million US$ and it is expected to reach 5830 million US$ by the end of 2025, with a CAGR of 15.0% during 2019-2025.

This report focuses on the global Sickle Cell Anemia Treatment status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sickle Cell Anemia Treatment development in United States, Europe and China.

The key players covered in this study
Addmedica
Gamida Cell
GlycoMimetics
Pfizer
Novartis
Global Blood Therapeutics
Micelle BioPharma
Bluebird Bio
Prolong Pharmaceuticals
Modus Therapeutics
Sangamo Biosciences
Bioverativ
Imara
Ironwood Pharmaceuticals

Market segment by Type, the product can be split into
Blood Transfusion
Pharmacotherapy
Bone Marrow Transplant

Market segment by Application, split into
Child
Adult

Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Sickle Cell Anemia Treatment status, future forecast, growth opportunity, key market and key players.
To present the Sickle Cell Anemia Treatment development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sickle Cell Anemia Treatment are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Sickle Cell Anemia Treatment Market Size Growth Rate by Type (2014-2025)
1.4.2 Blood Transfusion
1.4.3 Pharmacotherapy
1.4.4 Bone Marrow Transplant
1.5 Market by Application
1.5.1 Global Sickle Cell Anemia Treatment Market Share by Application (2014-2025)
1.5.2 Child
1.5.3 Adult
1.6 Study Objectives
1.7 Years Considered

2 Global Growth Trends
2.1 Sickle Cell Anemia Treatment Market Size
2.2 Sickle Cell Anemia Treatment Growth Trends by Regions
2.2.1 Sickle Cell Anemia Treatment Market Size by Regions (2014-2025)
2.2.2 Sickle Cell Anemia Treatment Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities

3 Market Share by Key Players
3.1 Sickle Cell Anemia Treatment Market Size by Manufacturers
3.1.1 Global Sickle Cell Anemia Treatment Revenue by Manufacturers (2014-2019)
3.1.2 Global Sickle Cell Anemia Treatment Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Sickle Cell Anemia Treatment Market Concentration Ratio (CR5 and HHI)
3.2 Sickle Cell Anemia Treatment Key Players Head office and Area Served
3.3 Key Players Sickle Cell Anemia Treatment Product/Solution/Service
3.4 Date of Enter into Sickle Cell Anemia Treatment Market
3.5 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Sickle Cell Anemia Treatment Market Size by Type (2014-2019)
4.2 Global Sickle Cell Anemia Treatment Market Size by Application (2014-2019)

5 United States
5.1 United States Sickle Cell Anemia Treatment Market Size (2014-2019)
5.2 Sickle Cell Anemia Treatment Key Players in United States
5.3 United States Sickle Cell Anemia Treatment Market Size by Type
5.4 United States Sickle Cell Anemia Treatment Market Size by Application

6 Europe
6.1 Europe Sickle Cell Anemia Treatment Market Size (2014-2019)
6.2 Sickle Cell Anemia Treatment Key Players in Europe
6.3 Europe Sickle Cell Anemia Treatment Market Size by Type
6.4 Europe Sickle Cell Anemia Treatment Market Size by Application

7 China
7.1 China Sickle Cell Anemia Treatment Market Size (2014-2019)
7.2 Sickle Cell Anemia Treatment Key Players in China
7.3 China Sickle Cell Anemia Treatment Market Size by Type
7.4 China Sickle Cell Anemia Treatment Market Size by Application

8 Japan
8.1 Japan Sickle Cell Anemia Treatment Market Size (2014-2019)
8.2 Sickle Cell Anemia Treatment Key Players in Japan
8.3 Japan Sickle Cell Anemia Treatment Market Size by Type
8.4 Japan Sickle Cell Anemia Treatment Market Size by Application

9 Southeast Asia
9.1 Southeast Asia Sickle Cell Anemia Treatment Market Size (2014-2019)
9.2 Sickle Cell Anemia Treatment Key Players in Southeast Asia
9.3 Southeast Asia Sickle Cell Anemia Treatment Market Size by Type
9.4 Southeast Asia Sickle Cell Anemia Treatment Market Size by Application

10 India
10.1 India Sickle Cell Anemia Treatment Market Size (2014-2019)
10.2 Sickle Cell Anemia Treatment Key Players in India
10.3 India Sickle Cell Anemia Treatment Market Size by Type
10.4 India Sickle Cell Anemia Treatment Market Size by Application

11 Central & South America
11.1 Central & South America Sickle Cell Anemia Treatment Market Size (2014-2019)
11.2 Sickle Cell Anemia Treatment Key Players in Central & South America
11.3 Central & South America Sickle Cell Anemia Treatment Market Size by Type
11.4 Central & South America Sickle Cell Anemia Treatment Market Size by Application

12 International Players Profiles
12.1 Addmedica
12.1.1 Addmedica Company Details
12.1.2 Company Description and Business Overview
12.1.3 Sickle Cell Anemia Treatment Introduction
12.1.4 Addmedica Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.1.5 Addmedica Recent Development
12.2 Gamida Cell
12.2.1 Gamida Cell Company Details
12.2.2 Company Description and Business Overview
12.2.3 Sickle Cell Anemia Treatment Introduction
12.2.4 Gamida Cell Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.2.5 Gamida Cell Recent Development
12.3 GlycoMimetics
12.3.1 GlycoMimetics Company Details
12.3.2 Company Description and Business Overview
12.3.3 Sickle Cell Anemia Treatment Introduction
12.3.4 GlycoMimetics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.3.5 GlycoMimetics Recent Development
12.4 Pfizer
12.4.1 Pfizer Company Details
12.4.2 Company Description and Business Overview
12.4.3 Sickle Cell Anemia Treatment Introduction
12.4.4 Pfizer Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.4.5 Pfizer Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Sickle Cell Anemia Treatment Introduction
12.5.4 Novartis Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.5.5 Novartis Recent Development
12.6 Global Blood Therapeutics
12.6.1 Global Blood Therapeutics Company Details
12.6.2 Company Description and Business Overview
12.6.3 Sickle Cell Anemia Treatment Introduction
12.6.4 Global Blood Therapeutics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.6.5 Global Blood Therapeutics Recent Development
12.7 Micelle BioPharma
12.7.1 Micelle BioPharma Company Details
12.7.2 Company Description and Business Overview
12.7.3 Sickle Cell Anemia Treatment Introduction
12.7.4 Micelle BioPharma Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.7.5 Micelle BioPharma Recent Development
12.8 Bluebird Bio
12.8.1 Bluebird Bio Company Details
12.8.2 Company Description and Business Overview
12.8.3 Sickle Cell Anemia Treatment Introduction
12.8.4 Bluebird Bio Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.8.5 Bluebird Bio Recent Development
12.9 Prolong Pharmaceuticals
12.9.1 Prolong Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Sickle Cell Anemia Treatment Introduction
12.9.4 Prolong Pharmaceuticals Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.9.5 Prolong Pharmaceuticals Recent Development
12.10 Modus Therapeutics
12.10.1 Modus Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Sickle Cell Anemia Treatment Introduction
12.10.4 Modus Therapeutics Revenue in Sickle Cell Anemia Treatment Business (2014-2019)
12.10.5 Modus Therapeutics Recent Development
12.11 Sangamo Biosciences
12.12 Bioverativ
12.13 Imara
12.14 Ironwood Pharmaceuticals

13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)

14 Analyst's Viewpoints/Conclusions

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details